Matches in SemOpenAlex for { <https://semopenalex.org/work/W1988604278> ?p ?o ?g. }
- W1988604278 endingPage "557" @default.
- W1988604278 startingPage "548" @default.
- W1988604278 abstract "Atrial fibrillation (AF) in heart failure (HF) is generally considered a negative prognostic factor. Recent studies indicate that the incidence of AF might be decreased by renin angiotensin aldosterone system inhibitors. The identification of a treatment to prevent its occurrence is likely to improve patients outcome. The aims of these subanalyses of Val-HeFT were to assess (a) the effects of valsartan in the prevention of AF, (b) the independent predictors of this event, and (c) the prognostic role of AF occurrence. The occurrence of AF was evaluated based on adverse event reports in the patients with HF enrolled in Val-HeFT. Patients were randomized to valsartan or placebo on top of their prescribed treatments for HF. During the mean 23 months of follow-up, AF was reported in 287/4395 patients (6.53%) in sinus rhythm at baseline, of whom 113/2205 (5.12%) were allocated to valsartan and 174/2190 (7.95%) to placebo (P = .0002). Multivariable analysis showed that brain natriuretic peptide (BNP) levels at baseline above the median value (HR 2.28, 95% CI 1.75-2.98), age over 70 years (HR 1.51, 95% CI 1.17-1.95), male sex (HR 1.53, 95% CI 1.07-2.18), and the valsartan treatment (HR 0.63, 95% CI 0.49-0.81) were independently associated with AF occurrence. Cox multivariable regression analysis showed that occurrence of AF was independently associated with a worse prognosis, with the adjusted hazard risks for all-cause mortality and combined mortality/morbidity of 1.40 (95% CI 1.16-1.58) and 1.38 (95% CI 1.12-1.70), respectively. The results of the present study demonstrate that (a) adding valsartan to prescribed therapy for HF significantly reduces the incidence of AF by 37%; (b) BNP level and advanced age were the strongest independent predictors for AF occurrence; and (c) AF occurrence further worsens the outcome in patients with HF." @default.
- W1988604278 created "2016-06-24" @default.
- W1988604278 creator A5002108547 @default.
- W1988604278 creator A5005350140 @default.
- W1988604278 creator A5008695398 @default.
- W1988604278 creator A5018464718 @default.
- W1988604278 creator A5027518592 @default.
- W1988604278 creator A5039697719 @default.
- W1988604278 creator A5061915173 @default.
- W1988604278 creator A5086200860 @default.
- W1988604278 creator A5088186128 @default.
- W1988604278 creator A5088399069 @default.
- W1988604278 date "2005-03-01" @default.
- W1988604278 modified "2023-10-18" @default.
- W1988604278 title "Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)" @default.
- W1988604278 cites W1430322293 @default.
- W1988604278 cites W1965692683 @default.
- W1988604278 cites W1966087026 @default.
- W1988604278 cites W1973222295 @default.
- W1988604278 cites W1980825716 @default.
- W1988604278 cites W1999850772 @default.
- W1988604278 cites W2003664440 @default.
- W1988604278 cites W2012872595 @default.
- W1988604278 cites W2017179259 @default.
- W1988604278 cites W2029191989 @default.
- W1988604278 cites W2034679251 @default.
- W1988604278 cites W2056893352 @default.
- W1988604278 cites W2058986936 @default.
- W1988604278 cites W2062206620 @default.
- W1988604278 cites W2098780362 @default.
- W1988604278 cites W2099601272 @default.
- W1988604278 cites W2102747832 @default.
- W1988604278 cites W2119620212 @default.
- W1988604278 cites W2127818427 @default.
- W1988604278 cites W2129967926 @default.
- W1988604278 cites W2133217116 @default.
- W1988604278 cites W2135038122 @default.
- W1988604278 cites W2158880436 @default.
- W1988604278 cites W2164029652 @default.
- W1988604278 cites W2324628668 @default.
- W1988604278 cites W2326579808 @default.
- W1988604278 cites W2614763070 @default.
- W1988604278 cites W3021063182 @default.
- W1988604278 cites W40891977 @default.
- W1988604278 cites W52877415 @default.
- W1988604278 doi "https://doi.org/10.1016/j.ahj.2004.09.033" @default.
- W1988604278 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15864246" @default.
- W1988604278 hasPublicationYear "2005" @default.
- W1988604278 type Work @default.
- W1988604278 sameAs 1988604278 @default.
- W1988604278 citedByCount "380" @default.
- W1988604278 countsByYear W19886042782012 @default.
- W1988604278 countsByYear W19886042782013 @default.
- W1988604278 countsByYear W19886042782014 @default.
- W1988604278 countsByYear W19886042782015 @default.
- W1988604278 countsByYear W19886042782016 @default.
- W1988604278 countsByYear W19886042782017 @default.
- W1988604278 countsByYear W19886042782018 @default.
- W1988604278 countsByYear W19886042782019 @default.
- W1988604278 countsByYear W19886042782020 @default.
- W1988604278 countsByYear W19886042782021 @default.
- W1988604278 countsByYear W19886042782022 @default.
- W1988604278 countsByYear W19886042782023 @default.
- W1988604278 crossrefType "journal-article" @default.
- W1988604278 hasAuthorship W1988604278A5002108547 @default.
- W1988604278 hasAuthorship W1988604278A5005350140 @default.
- W1988604278 hasAuthorship W1988604278A5008695398 @default.
- W1988604278 hasAuthorship W1988604278A5018464718 @default.
- W1988604278 hasAuthorship W1988604278A5027518592 @default.
- W1988604278 hasAuthorship W1988604278A5039697719 @default.
- W1988604278 hasAuthorship W1988604278A5061915173 @default.
- W1988604278 hasAuthorship W1988604278A5086200860 @default.
- W1988604278 hasAuthorship W1988604278A5088186128 @default.
- W1988604278 hasAuthorship W1988604278A5088399069 @default.
- W1988604278 hasConcept C120665830 @default.
- W1988604278 hasConcept C121332964 @default.
- W1988604278 hasConcept C126322002 @default.
- W1988604278 hasConcept C142724271 @default.
- W1988604278 hasConcept C164705383 @default.
- W1988604278 hasConcept C197934379 @default.
- W1988604278 hasConcept C204787440 @default.
- W1988604278 hasConcept C207103383 @default.
- W1988604278 hasConcept C27081682 @default.
- W1988604278 hasConcept C2775914520 @default.
- W1988604278 hasConcept C2777387769 @default.
- W1988604278 hasConcept C2778198053 @default.
- W1988604278 hasConcept C2779161974 @default.
- W1988604278 hasConcept C44249647 @default.
- W1988604278 hasConcept C50382708 @default.
- W1988604278 hasConcept C61511704 @default.
- W1988604278 hasConcept C71924100 @default.
- W1988604278 hasConcept C84393581 @default.
- W1988604278 hasConceptScore W1988604278C120665830 @default.
- W1988604278 hasConceptScore W1988604278C121332964 @default.
- W1988604278 hasConceptScore W1988604278C126322002 @default.
- W1988604278 hasConceptScore W1988604278C142724271 @default.
- W1988604278 hasConceptScore W1988604278C164705383 @default.
- W1988604278 hasConceptScore W1988604278C197934379 @default.